Aster DM Quality Care receives NSE trading approval for equity shares allotted under amalgamation scheme

M&A / JV 14 Aug 2026 · Completed· ✓ Verified

Aster DM Quality Care Limited, a publicly-listed healthcare provider, completed a Scheme of Amalgamation and allotted equity shares to the shareholders of the merged entity. The NSE granted trading approval for these allotted shares on 14 August 2026, confirming regulatory clearance for market-driven liquidity. The scheme had undergone prior NCLT sanction (details of order date and merged entity identity not disclosed in the NSE filing alone). No deal value or share-ratio was disclosed in the regulatory notification.

Why it mattersThe trading approval trigger is critical in amalgamation schemes involving publicly-listed entities: the allotment of shares to shareholders of the merged entity is completed only once the stock exchange permits secondary market trading, marking the effective date for valuation and disclosure purposes under Regulation 30 of the SEBI (LODR) Regulations.
Counsel—
SectorPharma & Healthcare
[object Object][object Object][object Object][object Object][object Object][object Object][object Object][object Object][object Object]

Sources

Open in the live tracker →

Related deals